Alessandro Paniccia, MD; Patrick Hosokawa, MS; William Henderson, PhD; et al.
free access
JAMA Surg. 2015;150(8):701-710. doi:10.1001/jamasurg.2015.0668
This cohort study observes characteristics associated with long-term survival of patients with pancreatic ductal adenocarcinoma and develops a nomogram to help identify potential long-term survivors.
-
Invited Commentary
Long-term Survival After Pancreatic Cancer: Hope Has Arrived
Mu Xu, MD, PhD; O. Joe Hines, MD
JAMA Surg
Pacific Coast Surgical Association
Colorectal Writing Group for the Surgical Care and Outcomes Assessment Program–Comparative Effectiveness Research Translation Network (SCOAP-CERTAIN) Collaborative
free access
has audio
JAMA Surg. 2015;150(8):712-720. doi:10.1001/jamasurg.2015.1057
This prospective study from the Washington State Surgical Care and Outcomes Assessment Program describes the thromboembolic complications and contemporary venous thromboembolism prophylaxis patterns in 16 115 consecutive patients undergoing colorectal surgery.
-
Audio Author Interview:
Thromboembolic Complications and Prophylaxis in Colorectal Surgery (JAMA Surgery)
Georgios Antonios Margonis, MD; Yuhree Kim, MD, MPH; Gaya Spolverato, MD; et al.
free access
JAMA Surg. 2015;150(8):722-729. doi:10.1001/jamasurg.2015.0313
This single-center study investigates the prognostic impact of specific KRAS mutations on the survival of patients undergoing liver resection for colorectal liver metastases.
Christoph Czarnetzki, MD, MBA; Nadia Elia, MD, MSc; Jean-Louis Frossard, MD; et al.
free access
JAMA Surg. 2015;150(8):730-737. doi:10.1001/jamasurg.2015.0306
This randomized clinical trial reports that erythromycin administration increases gastric emptying among patients undergoing emergency surgery under general anesthesia.
Yasuaki Sagara, MD; Melissa Anne Mallory, MD; Stephanie Wong, MD; et al.
free access
JAMA Surg. 2015;150(8):739-745. doi:10.1001/jamasurg.2015.0876
This cohort study uses SEER database data to investigate the survival benefit of breast surgery for low-grade ductal carcinoma in situ.
-
Invited Commentary
No Surgery for Low-Grade Ductal Carcinoma In Situ?
Julie A. Margenthaler, MD; Aislinn Vaughan, MD
JAMA Surg
Pragatheeshwar Thirunavukarasu, MD; Chetasi Talati, MD; Sumeet Munjal, MD; et al.
free access
JAMA Surg. 2015;150(8):747-755. doi:10.1001/jamasurg.2015.0871
This study of patients with colon cancer from the SEER database evaluated the effect of inclusion of C stage into standard cancer staging and the implications on survival estimates.
Pacific Coast Surgical Association
Wayne S. Lee, MD; Vincent E. Chong, MD, MS; Gregory P. Victorino, MD
free access
JAMA Surg. 2015;150(8):757-762. doi:10.1001/jamasurg.2015.1138
This medical record review describes the use of computed tomography in identifying the mortality risk in patients with pneumomediastinum due to blunt trauma.
Devin S. Zarkowsky, MD; Caitlin W. Hicks, MD, MS; Isibor Arhuidese, MD, MPH; et al.
free access
JAMA Surg. 2015;150(8):764-770. doi:10.1001/jamasurg.2015.1126
This analysis of the US Renal Data System identifies differing frequencies and mortality rates associated with the use of arteriovenous fistulas at first hemodialysis for end-stage renal disease.
Franz Yanagawa, MD; Martin Perez, MD; Ted Bell, MS; et al.
free access
JAMA Surg. 2015;150(8):771-777. doi:10.1001/jamasurg.2015.1098
This observational study uses the AHRQ Nationwide Inpatient Sample to compare complications, length of stay, actual cost, and mortality between nonrobotic and robotic-assisted cardiac surgical procedures.
Meeghan Lautner, MD, MSc; Heather Lin, PhD; Yu Shen, PhD; et al.
free access
JAMA Surg. 2015;150(8):778-786. doi:10.1001/jamasurg.2015.1102
This analysis of women with breast cancer in the National Cancer Data Base describes barriers to the use of breast-conserving therapy.
Kristina H. Lewis, MD, MPH, SM; Fang Zhang, PhD; David E. Arterburn, MD, MPH; et al.
free access
JAMA Surg. 2015;150(8):787-794. doi:10.1001/jamasurg.2015.1081
This interrupted time series with comparison series study reports that laparoscopic adjustable gastric banding and Roux-en-Y gastric bypass were associated with flattened total health care cost trajectories but Roux-en-Y gastric bypass patients experienced lower total and prescription costs by 3 years postsurgery.